Cargando…
PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring
Autores principales: | Woillard, JB, Bader-Meunier, B, Salomon, R, Ranchin, B, Decramer, S, Fischbach, M, Berard, E, Saint-Marcoux, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044698/ http://dx.doi.org/10.1186/1546-0096-11-S2-O10 |
Ejemplares similares
-
Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus?
por: Jurado, C, et al.
Publicado: (2011) -
Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study
por: Noreikaitė, Aurelija, et al.
Publicado: (2017) -
Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022) -
Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension
por: Machireddy, Kirthi, et al.
Publicado: (2018)